Clinical Trials Browser

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Clinical Trials

INSPIRE

In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

PM-CARE

Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma

COMPASS-B-MUHC

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

BESTDRAIN

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC

OPTIMAL

MK-3475-E90

Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

VUBAR

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

CCGLC-012

CCGLC-009

Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC

CISPD-5

Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy

ADBoard

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

Hepatobiliary Tumors Tissue Samples Acquisition

Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Clinical Trial of Autologous Tcm Immunotherapy in ICC

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

A Study of ICP-192 in Patients With Advanced Solid Tumors

AI Guidance for Biopsy in Suspected Cholangiocarcinoma

Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients

FOCUS

Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Advanced or Metastatic Cholangiocarcinoma

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma

Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma